New Key Statistics Module, Z-Score and F-Score
XCNQ:BIOV Key Ratios
Market Cap C$ M | 18.52 |
Enterprise Value C$ M | 18.43 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | -- |
EPS (TTM) C$ | -0.04 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -3.25 |
EV-to-EBITDA | -3.25 |
PEG | -- |
Shares Outstanding M | 246.93 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 0.14 |
Current Ratio | 0.14 |
ROA % (ttm) | -354.80 |
ROE % (ttm) | -- |
ROIC % (ttm) | -646.69 |
Dividend Yield % | -- |
Altman Z-Score | -- |
XCNQ:BIOV Number of Guru Trades
XCNQ:BIOV Volume of Guru Trades
Gurus Latest Trades with XCNQ:BIOV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XCNQ:BIOV is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
BioVaxys Technology Corp Insider Transactions
No Available Data